To Develop and Validate the Predictive Warfarin Dosing Algorithm [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples With DNA

Blood samples were taken from patients for genotyping about 8ml

Enrollment:

405

Study Start Date:

March 2008

Study Completion Date:

April 2010

Primary Completion Date:

April 2010 (Final data collection date for primary outcome measure)

Detailed Description:

This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.

Eligibility

Ages Eligible for Study:

20 Years and older (Adult, Senior)

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Probability Sample

Study Population

the patients taking warfarin

Criteria

Inclusion Criteria:

the patients taking warfarin

Exclusion Criteria:

noncompliance

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01178502

Locations

Korea, Republic of

Inje University

Busan, Korea, Republic of, 614-735

Sponsors and Collaborators

Inje University

More Information

Responsible Party:

Jae-Gook Shin, Department of Pharmacology and Pharmacogenomics Research Center, Inje University